Clinical Trials Sponsored by HydroDot, Inc.
Total 35375 results
-
Beth Israel Deaconess Medical CenterHydroDot, Inc.CompletedEpilepsy | SeizuresUnited States
-
IND Diagnostic Inc.Unknown
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.; Oncoceutics, Inc.RecruitingMetastasis | Endometrial CancerUnited States
-
NC Medial Research IncRecruiting
-
IC-IT Sciences Inc.UnknownSleep DisturbanceUnited States
-
Zhengzhou Gensciences IncHaimen Gensciences lncCompleted
-
Zhengzhou Gensciences IncJiangsu Gensciences lnc.Completed
-
UNC Lineberger Comprehensive Cancer CenterSeagen Inc.CompletedHodgkin Lymphoma, AdultUnited States
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.TerminatedGraft Versus Host DiseaseUnited States
-
UNC Lineberger Comprehensive Cancer CenterVeracyte, Inc.RecruitingBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterSeagen Inc.Active, not recruitingLymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/LymphomaUnited States
-
IGC Pharma LLCCompletedDementia of Alzheimer TypePuerto Rico
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.CompletedHematologic Malignancies | Malignant Solid TumorUnited States
-
IGC Pharma LLCRecruitingAggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive OutburstUnited States, Canada, Puerto Rico
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.RecruitingDiffuse Large B-cell LymphomaUnited States
-
Novan, Inc.Synteract, Inc.; Therapeutics, Inc.CompletedMolluscum ContagiosumUnited States
-
OBELAB, Inc.Helptrial Inc.Not yet recruitingAcute Ischemic Stroke PatientsKorea, Republic of
-
Athersys, IncMedpace, Inc.RecruitingIschemic StrokeUnited States, Taiwan
-
89bio, Inc.ProSciento, Inc.Completed
-
ModernaTX, Inc.Aetion, Inc.Active, not recruiting
-
Eisai Inc.Quintiles, Inc.TerminatedColorectal CancerUnited States, Australia, Russian Federation, India, Ukraine
-
AxeroVision, Inc.ORA, Inc.CompletedDry EyeUnited States
-
Versartis Inc.Completed
-
Novan, Inc.Synteract, Inc.CompletedMolluscum ContagiosumUnited States
-
EmitBio Inc.Completed
-
Xoft, Inc.Icad, Inc.WithdrawnDuctal Carcinoma In Situ | Invasive Ductal Carcinoma
-
Versartis Inc.CompletedPediatric Growth Hormone DeficiencyUnited States
-
EmitBio Inc.CompletedCOVID19United States
-
Mylan Inc.CompletedCystic FibrosisUnited States
-
Evofem Inc.Neothetics, IncTerminatedCentral Abdominal Bulging
-
Healios Inc.Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Evofem Inc.Neothetics, IncCompletedCentral Abdominal BulgingUnited States
-
Eisai Inc.Quintiles, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Previously Untreated Gastric CancerUnited States, Russian Federation, United Kingdom, Ukraine
-
Seagen Inc.Genentech, Inc.CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
Seagen Inc.Genentech, Inc.Completed
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Seagen Inc.Genentech, Inc.CompletedLeukemia, Lymphocytic, ChronicUnited States
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Essentialis, Inc.Medpace, Inc.CompletedDyslipidemia | Hypertriglyceridemia
-
Seagen Inc.Agensys, Inc.CompletedPancreatic Neoplasms | Gastric NeoplasmsUnited States
-
Pamlab, Inc.InfoMedics, Inc.CompletedMild Cognitive Impairment | Vascular Dementia | Alzheimer's Disease | Early Memory LossUnited States
-
Santen Inc.MacuSight, Inc.CompletedDiabetic Macular EdemaUnited States
-
Esanex Inc.Serenex, Inc.CompletedHematologic NeoplasmsUnited States
-
Essentialis, Inc.Medpace, Inc.Completed
-
Santen Inc.MacuSight, Inc.CompletedDiabetic Retinopathy | Diabetic Macular EdemaUnited States
-
University in Zielona GóraConvaTec Inc.UnknownBreast Cancer | Breast ReconstructionPoland
-
Vitality in Aging Research Group, Inc.Withdrawn
-
In-Home Addiction Treatment Institute, Inc.Suspended
-
Astellas Pharma IncSeagen Inc.; Agensys, Inc.CompletedNeoplasms | Tumors | Medical OncologyUnited States, Canada
-
EmitBio Inc.Recruiting